Is Tarsus Pharmaceuticals, Inc. (TARS) a Buy, Sell, or Hold?
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$56.11 USD
-$3.2 (-5.4%)
- Volume
- 2.08M
- Average Volume
- 881.37K
- Market Capitalization
- $2.41B
- P/E Ratio
- -49.22
- Dividend Yield
- 0.00%
- Price Target
- $68.00
- Year High
- $85.25
- Year Low
- $38.51
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.74
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
3.42%
Investors Holding
14
change: -246 | last: 260
Increased Positions
6
change: -131 | last: 137
Reduced Positions
4
change: -78 | last: 82
New Positions
2
change: -45 | last: 47
Sold Positions
242
change: 202 | last: 40
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -76.3303 | last: 0.7633
Total Invested
92.42M
TARS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $81.88 | 41.78M | $3.42B | $183.64M | $93.64M | $3.33B |
| 2024-12-31 | $55.37 | 37.6M | $2.08B | $94.82M | $72.45M | $2.06B |
| 2023-12-31 | $20.25 | 29.38M | $595.01M | $224.95M | $30.22M | $400.28M |
| 2022-12-31 | $14.66 | 24.62M | $360.92M | $71.66M | $20.21M | $309.47M |
| 2021-12-31 | $22.50 | 20.55M | $462.47M | $171.33M | $1.89M | $293.03M |
| 2020-12-31 | $41.33 | 20.32M | $839.96M | $168.13M | $831K | $672.66M |
| 2019-12-31 | $20.58 | 19.51M | $401.5M | $57.95M | $164K | $343.71M |
| 2018-12-31 | $20.58 | 4.29M | $88.19M | $2.36M | $- | $85.84M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $70.15 | 42.96M | $3.01B | $102.19M | $88.68M | $3B |
| 2025-12-31 | $81.88 | 42.78M | $3.5B | $183.64M | $93.64M | $3.41B |
| 2025-09-30 | $59.43 | 42.61M | $2.53B | $112.72M | $82.51M | $2.5B |
| 2025-06-30 | $40.51 | 42.36M | $1.72B | $96.65M | $72.45M | $1.69B |
| 2025-03-31 | $51.37 | 39.35M | $2.02B | $175.79M | $72.37M | $1.92B |
| 2024-12-31 | $55.37 | 38.56M | $2.14B | $94.82M | $72.45M | $2.11B |
| 2024-09-30 | $32.89 | 38.38M | $1.26B | $176.21M | $72.34M | $1.16B |
| 2024-06-30 | $28.24 | 37.82M | $1.07B | $181.1M | $72.18M | $959.22M |
| 2024-03-31 | $35.85 | 35.3M | $1.27B | $193.7M | $30.52M | $1.1B |
| 2023-12-31 | $20.25 | 31.94M | $646.87M | $224.95M | $30.22M | $452.14M |
| 2023-09-30 | $17.77 | 30.62M | $544.16M | $226.67M | $30.13M | $347.62M |
| 2023-06-30 | $18.07 | 26.82M | $484.56M | $106.77M | $25.04M | $402.83M |